Defendant Name:
Teva Pharmaceutical Industries Limited
Defendant Type:
Public Company
SIC Code:
2834
CUSIP:
88162420
Document Reference:
comp_pr2016-277
Document Details
Legal Case Name
SEC v. Teva Pharmaceutical Industries Ltd.
Document Name
Complaint
Document Date
22-Dec-2016
Document Format
Civil Proceeding
Case Number
16-cv-25298
Federal District Court
Florida, Southern District of Florida
Allegation Type
Foreign Corrupt Practices Act
Document Summary
According to the SEC "From at least October 2010 through at least December 2012, Teva paid bribes to a government official in Russia. From at least May 2002 through March 2011, Teva paid bribes to a government official in Ukraine. In 2011 and 2012, a Teva subsidiary in Mexico also paid bribes to government officials in Mexico. These illegal payments were made to influence regulatory and formulary approvals, drug purchase decisions, prescription decisions, and to increase Teva's market share and develop competitive advantages over competitors. Teva realized more than $214,596,170 in profits from business obtained through the use of illegal
payments. "